One of the major tasks of the postgenomic era is high-throughput protein expression. To analyze functionally the genes encoded by the sequence dataset, rapid screening methods are of major interest. Many cDNA libraries and collections of cloned open reading frames have been constructed so far, and to screen for expressed proteins, these coding sequences have to be inserted into expression vectors. The steps needed for this conversion by either conventional cloning or recombination techniques are time consuming and difficult to adapt to high-throughput applications. By combining a powerful PCR technique to generate linear expression constructs with an in vitro protein expression method based on T7 RNA polymerase, existing collections of plasmids harboring open reading frames can easily be converted into constructs suitable for in vitro expression.
Using common procedures of expression-PCR, an individual set of primers is required to construct expression fragments for different genes (1,3,4). In our approach, plasmid-specific instead of gene-specific primers were used to convert cloned open reading frames into expression fragments. Universal oligonucleotides binding to vector-specific sequences up-and downstream of the inserts were designed (Figure 1 ). Different genes inserted into plasmids by two recombination techniques were selected as templates for the first reactions (6) . To introduce T7-regulatory elements (e.g., T7 promoter, ribosomal binding site, T7 terminator), an overlap extension PCR using the Rapid Translation System (RTS) E. coli Linear Template Generation Set (Roche Diagnostics GmbH, Mannheim, Germany) was performed (5) . To create an overlap region, approximately 20 bp were added to the 5′ end of the 18-nucleotide-long vectorspecific part of the primers. The length of the vector-specific part of the primers was selected to ensure a correct open reading frame of the genes. For amplification of open reading frames inserted in plasmid pDONR201 (GATEWAY; Invitrogen, Carlsbad, CA, USA), the oligonucleotides were designed as follows: forward primer‚ att-sense 5′-CGCTTAATTAAACATATGACCttgtacaaaaaagcaggc-3′ and reverse primer‚ att-antisense 5′-TTAGTTAGTTACCGGATCCCtttgtacaagaaag ctgg-3′ (the overlap regions in capital letters and vector-specific parts in lowercase letters). In case of pDNR-Dual plasmids constructed with the In-Fusion PCR Cloning Kit (Creator; BD Biosciences Clontech, Palo Alto, CA, USA), the set of oligonucleotides was designed as follows: Creator-sense, 5′-CGCTTAATTAAACATATGACCacgaagttatcagtcgac-3′, and Creator-antisense, 5′-TTAGTTAGTTACCGGATCCCgaatggtctagaaagctt-3′. The selected sets of primers were used to introduce either an N-terminal His 6 -tag or hemagglutinin epitope-tag, using the RTS E. coli Linear Template Generation Sets (data shown for introduction of N-terminal His 6 -tag).
In summary, nine genes cloned in pDNR-Dual and 23 genes cloned in pDONR201 were investigated. PCR amplification was performed in 50-µL reactions with 10-50 ng template DNA, 20 pmol each sense and antisense primers, 1× PCR buffer, 3 mM MgCl 2 , 0.2 mM dNTPs, and 3 U DNA polymerase mixture (Expand High Fidelity PCR System; Roche Diagnostics GmbH). The following temperature profile was used for the first PCRs: 4 min at 94°C, 25 cycles of 30 s at 94°C, 1 min at 50°C, 3 min at 72°C, and 10 min at 72°C. The products of the first reactions were analyzed on agarose gels ( Figure 2A ). As template for the overlap extension reactions, 2 µL of the first products were added, corresponding to a final concentration of approximately 3 nM. To introduce T7-regulatory elements and a tag sequence, 1 µL N-terminal His 6 -tag DNA of the RTS E. coli Linear Template Generation Set was added to a 50-µL PCR. The second PCRs were performed following the instruction manual, using the following temperature profile: 4 min at 94°C, 20 cycles of 1 min at 94°C, 1 min at 60°C, and 3.5 min at 72°C, and 10 min at 72°C. Compared to the first PCR products, the second PCR products were 360 bp longer, which was caused by the introduction of regulatory elements and the tag sequence ( Figure 2B ).
In vitro protein expression was performed with RTS 100 E. coli HY Kits (Roche Diagnostics GmbH) with 2-4 µL of the second PCR product (corresponding to a final concentration of 1.5-3 nM) in 50-µL volumes. All PCRs and expression reactions were performed in parallel using multichannel pipets. After 2 h incubation at 30°C, 1 µL of each sample was separated on SDS-polyacrylamide gels and blotted. Detection of His 6 -tagged proteins was carried out with an anti-pentahistidine primary antibody (Qiagen, Hilden, Germany) and visualized by chemiluminescent detection with POD-conjugated sheep anti-mouse IgG and LumiLight PLUS Western Blotting Substrate (both from Roche Diagnostics GmbH).
Benchmarks
As shown in Figure 2C , seven of nine pDNR-Dual clones were successfully expressed by expression-PCR. Starting from pDONR201 clones, 15 of 23 proteins were detected in relatively high yields with anti-histidine antibodies. Among the 32 clones investigated, a total of four clones showed low expression rates, whereas another four clones were not detectable. Nevertheless, with a positive protein signal in 87% of the clones, a relatively high success rate was achieved.
Depending on the nature and the folding of a protein, tag sequences can be hidden and hardly accessible for detecting antibodies. Furthermore, the generation of stop codons by PCRcaused point mutations could lead to small, undetectable protein fragments, which might explain a missing signal on Western blots. One of the major advantages of expression in vitro compared to in vivo is the tolerance towards high amounts of recombinant proteins and toxic proteins. Nevertheless, proteins that interfere with the in vitro expression machinery or block the energy supply of the system could also lead to a failure of expression.
The proteins successfully expressed were densitometrically quantified on Western blots using the molecular weight marker proteins as a standard. Per reaction, 1-10 µg recombinant proteins were present. These protein amounts are largely sufficient for activity assays and further applications. As for every tagged recombinant protein, a potential inhibitory effect of any additionally added sequence (e.g., amino acids resulting from the recombination sites) cannot be excluded.
The common procedures of recombination and expression require several time-consuming steps such as shuttling the genes from entry clones to expression vectors, transformation of E. coli cells, plasmid preparation, transformation of an expression strain such as BL21(DE3), followed by expression, cell harvesting, and cell lysis. Combining the proposed PCR procedure with a rapid in vitro protein expression technology, the time required to express proteins is shortened to only 12 h (2,7). For a specific plasmid or library, only a single set of oligonucleotides is required, and the PCR conditions have to be adapted only once. As a main advantage, the method opens the possibility to adapt the individual steps to 96-well format and to automate the whole expression process. 
Titration of Non-Occluded Baculovirus Using a Cell Viability Assay
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The insect cell-baculovirus system is a transient expression system in which the gene of the protein of interest is delivered to the insect cell by a recombinant baculovirus. It has been shown that the final concentration and the rate of expression of the recombinant protein are determined by the multiplicity of infection (MOI) employed (10,12). Accurate MOI can only be obtained when the baculovirus stock is titrated with a precise and reproducible method. Unfortunately, commonly utilized methods, such as the endpoint dilution assay, have a very high variability. This variability is inherent to biological entities, but it is also a result of the qualitative evaluation methods used for identifying infected cells, especially when a reporter protein, such as β-galactosidase, is not available. Such qualitative evaluation methods are based on the subjective differentiation of infected from uninfected cells, which can only be accurately performed by highly trained personnel on a labor-intensive task. The variability of virus titering assays has been recognized by regulating agencies, which accept variations of viral titers of ±0.5 log 10 (4). Reducing the subjectivity and variability of virus titering assays would increase the reproducibility between runs infected with different viral stocks. Accurate virus titration is especially relevant in production strategies where two or more recombinant baculoviruses (each encoding for a different protein) are simultaneously used, such as in virus-like particle production. In particular, it has been shown that the stoichiometry between the recombinant proteins depends on the ratio between MOIs of each baculovirus (10,12).
Several fast and less subjective methods for baculovirus titration have been proposed. Most rely on a reporter protein, such as GFP or β-galactosidase, for identiying infected wells in endpoint dilution assays (1,13). However, a reporter protein is not always available or desirable. Others rely on the use of antibodies against baculoviral proteins and require expensive immunoreagents not widely available (5) . In this work, virus titration was performed utilizing a viability assay based on the cleavage of the tetrazolium ring of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT; Sigma-Aldrich, St. Louis, MO, USA) by a mitochondrial dehydrogenase in viable cells (8). The resulting product, a magenta water insoluble formazan salt, allows the objective quantification of viable cells through the use of a spectrophotometer. Because the baculovirus is a lytic virus, it can be expected that infection will reduce cell growth. Such a reduction should be dose-dependent and can be estimated by measuring the viable cell concentration using MTT and can be correlated to the viral titer. MTT viability assays have been previously used for the titration of virus, [e.g., rotavirus (3)] or for titering antiviral compounds (6, 11) .
The first step for the setup of the assay was to obtain a curve of viable cell concentration against the absorbance of the formazan salt produced. Exponentially growing Sf9 insect cells (ATCC CRL1711) with a viability higher than 95% were used in all assays. From 1 × 10 3 to 2 × 10 6 viable cells per well were seeded in flat-bottomed 96-well plates in 50 µL Sf900II medium (Invitrogen, Carlsbad, CA, USA). MTT stock solution (10 µL; 5 g/L) was added to each well. Plates were incubated in agitation for 2 h, centrifuged at 2000× g for 10 min in an Eppendorf ® 5810R centrifuge (Hamburg, Germany), and the supernatants were discarded. The magenta salt crystals were solubilized with 50 µL DMSO or acidified isopropanol (0.1 M HCl). As crystals were solubilized faster in DMSO and isopropanol was volatile, DMSO was used in all subsequent assays. Absorbance was measured at 570 nm in a microplate reader (model 550; Bio-Rad Laboratories, Hercules, CA, USA). The assay proved to be linear (abs = 8 × 10 -6 x + 0.0147 R 2 = 0.9952, where x is viable cell concentration) at cell concentrations below 50 000 cells/well. From this result, it was decided to seed 5 × 10 3 cells/well for titration assays. Such low initial cell concentration allowed that the response remained linear even if cell growth occurred during the incubation time.
Viral stocks of three different recombinant baculoviruses (Autographa californica nucleopolyhedrovirus) were titrated using the proposed method. They contain the genes for human placental secreted alkaline phosphatase (SeAP, kindly donated by Dr. Alan Wood, BTI, Cornell University, Ithaca, NY, USA), VP6 of rotavirus SA11 (kindly donated by Dr. S. López, IBT-UNAM, Mexico), and the fused gene of GFP and VP2 of rotavirus (kindly donated by Prof. J. Cohen, INRA, France) (2). All recombinant genes were under control of the polh promoter. Two plates were used for the titration of each viral stock. Ten microliters of serial dilutions of the viral stock (from 1 to 1 × 10 -10 ) were added to the plates, using 16 wells/dilution and 16 wells as uninfected controls. Six days after infection, Benchmarks
